Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
2751
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.23M | ﹤0.01% |
315,061
-1,040,034
| -77% | -$15M |
|
2752
Credicorp
BAP
$32B
| $4.23M | ﹤0.01% |
28,672
+26,410
| +1,168% | +$3.62M |
|
2753
PUT
Lightspeed Commerce
LSPD
$1.27B
| $4.23M | ﹤0.01% |
+250,000
| New | +$3.59M |
|
2754
HEICO Corp
HEI
$49.5B
| $4.22M | ﹤0.01% |
23,867
-96,591
| -80% | -$16.3M |
|
|
FORG
2755
DELISTED
ForgeRock, Inc.
FORG
| $4.21M | ﹤0.01% |
204,961
-46,780
| -19% | -$937K |
|
2756
PUT
Molson Coors Class B
TAP
$7.79B
| $4.21M | ﹤0.01% |
63,900
-200
| -0.3% | -$12.4K |
|
2757
Advance Auto Parts
AAP
$3.39B
| $4.21M | ﹤0.01% |
59,824
-1,448,903
| -96% | -$149M |
|
2758
PUT
ARK Blockchain & Fintech Innovation ETF
ARKF
$737M
| $4.2M | ﹤0.01% |
+201,000
| New | +$3.82M |
|
2759
PUT
Nasdaq
NDAQ
$53.2B
| $4.2M | ﹤0.01% |
84,300
-23,300
| -22% | -$1.26M |
|
2760
Nice
NICE
$5.79B
| $4.2M | ﹤0.01% |
20,335
+5,003
| +33% | +$1.03M |
|
2761
CALL
Lantheus
LNTH
$6.58B
| $4.2M | ﹤0.01% |
+50,000
| New | +$4.49M |
|
2762
Kura Oncology
KURA
$826M
| $4.19M | ﹤0.01% |
396,171
+374,981
| +1,770% | +$4.43M |
|
|
AIRC
2763
DELISTED
Apartment Income REIT Corp.
AIRC
| $4.19M | ﹤0.01% |
116,084
+46,470
| +67% | +$1.66M |
|
2764
PUT
PENN Entertainment
PENN
$2.75B
| $4.19M | ﹤0.01% |
174,300
-17,800
| -9% | -$474K |
|
2765
PUT
Williams Companies
WMB
$86.7B
| $4.18M | ﹤0.01% |
128,200
+52,900
| +70% | +$1.59M |
|
2766
CALL
Canadian Natural Resources
CNQ
$98.6B
| $4.18M | ﹤0.01% |
+148,600
| New | +$4.24M |
|
2767
Lindblad Expeditions
LIND
$1.95B
| $4.18M | ﹤0.01% |
384,100
-415,565
| -52% | -$4.27M |
|
2768
Sabre
SABR
$739M
| $4.17M | ﹤0.01% |
1,308,685
+409,647
| +46% | +$1.48M |
|
2769
CALL
Norfolk Southern
NSC
$75B
| $4.17M | ﹤0.01% |
18,400
-79,100
| -81% | -$16.8M |
|
2770
Clover Health Investments
CLOV
$2.29B
| $4.17M | ﹤0.01% |
4,650,918
+4,631,050
| +23,309% | +$4.11M |
|
2771
CALL
Arcus Biosciences
RCUS
$3.55B
| $4.17M | ﹤0.01% |
205,300
+95,300
| +87% | +$1.81M |
|
|
BSAQ
2772
DELISTED
Black Spade Acquisition Co
BSAQ
| $4.16M | ﹤0.01% |
402,616
+34,916
| +9% | +$359K |
|
2773
PUT
YPF
YPF
$20.4B
| $4.16M | ﹤0.01% |
+279,400
| New | +$3.39M |
|
2774
Aldeyra Therapeutics
ALDX
$96.5M
| $4.16M | ﹤0.01% |
495,575
-622,856
| -56% | -$6.14M |
|
2775
Codexis
CDXS
$159M
| $4.16M | ﹤0.01% |
1,484,928
+1,178,757
| +385% | +$3.81M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.